Recent News
Nov 3, 2025 — Option Care Health confirmed participation in multiple investor conferences in November and December, including UBS Global Healthcare and Jefferies London events. Late November 2025 — independent market ratings providers upgraded composite/relative-strength scores for the company, reflecting stronger price performance and institutional accumulation during the recent consolidation.
Technical Analysis
ADX at 18.62 indicates no dominant directional trend at present; directional indicators show weakening bullish breadth: DI+ peaked and reversed while DI- underwent a dip-and-reverse, both signaling increased downside pressure despite the lack of a strong trend. That combination raises near-term risk to upside continuation unless directional strength returns.
MACD sits slightly above its signal line (MACD 0.65 vs signal 0.59), which normally signals bullish conviction; the MACD trend shows a peak-and-reversal, however, indicating momentum has begun to weaken and that the recent bullish impulse may face exhaustion.
MRO registers 34.43 and shows an increasing trajectory; the positive oscillator indicates the market price currently sits above target levels and therefore carries a bias toward contraction from elevated levels, creating downside pressure that could compress short-term gains.
RSI at 54.66 with an increasing trend reflects mild bullish momentum without overbought conditions; RSI supports potential selective continuation but offers limited conviction absent stronger trend confirmation from ADX and MACD.
Price relationships favor short-term support: close at $30.59 sits above the 12-day and 20-day EMAs/averages (12-day EMA $30.04; 20-day avg $29.95) and above the 200-day average ($30.47), while the super trend lower support lies at $29.10. Bollinger bands place the close below the upper band, leaving room for upside but also vulnerability to a reversion toward the mid-band if momentum stalls.
Fundamental Analysis
Reported EPS of $0.45 exceeded the $0.43 estimate by $0.02, a +4.65% surprise, reflecting modest upside versus consensus expectations. EBITDA reached $100,161,000 with EBIT at $83,113,000, producing an EBIT margin of 5.79%, slightly above the industry peer mean of 5.51% and supporting a profitable operating profile relative to peers.
Top-line and cash-flow metrics present divergence. Total revenue stands at $1,435,016,000 while operating cash flow at $139,437,000 and free cash flow at $130,242,000 yield a free-cash-flow yield of 2.87%, which compares favorably to the industry peer mean of 1.52% and supports the company’s ability to fund buybacks and debt service.
Leverage and coverage show mixed fundamentals. Debt-to-EBITDA registers at 12.74x, indicating elevated leverage when measured against EBITDA. Debt-to-assets at 36.67% sits slightly above the industry peer mean of 32.48%, yet interest coverage stands at 5.88x, offering meaningful coverage of interest obligations.
Profitability and returns remain modest but positive: return on equity at 3.81% and return on assets at 1.51% both outperform their respective industry peer means, providing incremental support for valuation despite lower absolute returns. Asset turnover at 0.418 reflects the capital-intensive nature of the business and aligns with peer-level activity.
Recent intra-period dynamics show contraction: EBIT margin QoQ declined by 1.55 percentage points and YoY by 13.78 percentage points, while reported revenue growth metrics in the provided figures show QoQ and YoY declines. Those change rates warrant attention for their potential to pressure margins absent offsetting operational or pricing actions.
Valuation context: price-to-earnings at 62.94 and forward P/E near 92.10 present full multiple expansion relative to historical norms, while price-to-book at 3.34 falls slightly below the industry peer mean of 3.57. The current valuation, as determined by WMDST, registers as fair-valued given the combination of above-peer free cash generation, modest return metrics, and elevated leverage.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-09-30 |
| REPORT DATE: | 2025-10-30 |
| NEXT REPORT DATE: | 2026-01-29 |
| CASH FLOW | Begin Period Cash Flow | $ 198.8 M |
| Operating Cash Flow | $ 139.4 M | |
| Capital Expenditures | $ -9.20 M | |
| Change In Working Capital | $ 49.0 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 111.0 M | |
| End Period Cash Flow | $ 309.8 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 1.4 B | |
| Forward Revenue | $ 349.2 M | |
| COSTS | ||
| Cost Of Revenue | $ 1.2 B | |
| Depreciation | $ 17.0 M | |
| Depreciation and Amortization | $ 17.0 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 1.4 B | |
| PROFITABILITY | ||
| Gross Profit | $ 272.9 M | |
| EBITDA | $ 100.2 M | |
| EBIT | $ 83.1 M | |
| Operating Income | $ 84.5 M | |
| Interest Income | — | |
| Interest Expense | $ 14.1 M | |
| Net Interest Income | $ -14.15 M | |
| Income Before Tax | $ 69.0 M | |
| Tax Provision | $ 17.2 M | |
| Tax Rate | 24.9 % | |
| Net Income | $ 51.8 M | |
| Net Income From Continuing Operations | $ 51.8 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.43 | |
| EPS Actual | $ 0.45 | |
| EPS Difference | $ 0.02 | |
| EPS Surprise | 4.651 % | |
| Forward EPS | $ 0.32 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 3.5 B | |
| Intangible Assets | $ 1.9 B | |
| Net Tangible Assets | $ -566.43 M | |
| Total Current Assets | $ 1.3 B | |
| Cash and Short-Term Investments | $ 309.8 M | |
| Cash | $ 309.8 M | |
| Net Receivables | $ 474.5 M | |
| Inventory | $ 415.7 M | |
| Long-Term Investments | $ 45.2 M | |
| LIABILITIES | ||
| Accounts Payable | $ 627.9 M | |
| Short-Term Debt | $ 6.8 M | |
| Total Current Liabilities | $ 823.9 M | |
| Net Debt | $ 852.0 M | |
| Total Debt | $ 1.3 B | |
| Total Liabilities | $ 2.1 B | |
| EQUITY | ||
| Total Equity | $ 1.4 B | |
| Retained Earnings | $ 818.4 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 8.49 | |
| Shares Outstanding | 160.108 M | |
| Revenue Per-Share | $ 8.96 | |
| VALUATION | Market Capitalization | $ 4.5 B |
| Enterprise Value | $ 5.5 B | |
| Enterprise Multiple | 54.922 | |
| Enterprise Multiple QoQ | -6.506 % | |
| Enterprise Multiple YoY | 17.842 % | |
| Enterprise Multiple IPRWA | high: 190.244 OPCH: 54.922 median: 48.181 mean: -1.092 low: -219.035 |
|
| EV/R | 3.833 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.561 | |
| Asset To Liability | 1.641 | |
| Debt To Capital | 0.484 | |
| Debt To Assets | 0.367 | |
| Debt To Assets QoQ | 0.969 % | |
| Debt To Assets YoY | 19202.105 % | |
| Debt To Assets IPRWA | high: 0.956 OPCH: 0.367 mean: 0.325 median: 0.32 low: 0.004 |
|
| Debt To Equity | 0.939 | |
| Debt To Equity QoQ | 3.965 % | |
| Debt To Equity YoY | 20453.829 % | |
| Debt To Equity IPRWA | high: 2.466 median: 1.121 mean: 1.056 OPCH: 0.939 low: -1.645 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 3.338 | |
| Price To Book QoQ | -6.603 % | |
| Price To Book YoY | -8.275 % | |
| Price To Book IPRWA | high: 27.592 mean: 3.566 OPCH: 3.338 median: 1.785 low: -9.335 |
|
| Price To Earnings (P/E) | 62.939 | |
| Price To Earnings QoQ | -17.24 % | |
| Price To Earnings YoY | -36.031 % | |
| Price To Earnings IPRWA | high: 517.132 mean: 79.241 median: 64.535 OPCH: 62.939 low: -80.57 |
|
| PE/G Ratio | 6.451 | |
| Price To Sales (P/S) | 3.16 | |
| Price To Sales QoQ | -7.923 % | |
| Price To Sales YoY | -22.148 % | |
| Price To Sales IPRWA | high: 28.774 mean: 6.148 median: 4.136 OPCH: 3.16 low: 0.079 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 92.097 | |
| Forward PE/G | 9.44 | |
| Forward P/S | 12.986 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -0.175 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.418 | |
| Asset Turnover Ratio QoQ | -1.193 % | |
| Asset Turnover Ratio YoY | 10.825 % | |
| Asset Turnover Ratio IPRWA | high: 0.945 OPCH: 0.418 median: 0.397 mean: 0.332 low: 0.001 |
|
| Receivables Turnover | 3.003 | |
| Receivables Turnover Ratio QoQ | 1.565 % | |
| Receivables Turnover Ratio YoY | 5.368 % | |
| Receivables Turnover Ratio IPRWA | high: 9.084 mean: 4.366 OPCH: 3.003 median: 2.865 low: 0.147 |
|
| Inventory Turnover | 2.837 | |
| Inventory Turnover Ratio QoQ | -4.46 % | |
| Inventory Turnover Ratio YoY | -17.814 % | |
| Inventory Turnover Ratio IPRWA | high: 10.011 mean: 5.147 median: 4.892 OPCH: 2.837 low: 0.207 |
|
| Days Sales Outstanding (DSO) | 30.387 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 14.524 | |
| Cash Conversion Cycle Days QoQ | -9.719 % | |
| Cash Conversion Cycle Days YoY | 106.724 % | |
| Cash Conversion Cycle Days IPRWA | high: 132.972 median: 15.133 OPCH: 14.524 mean: 11.449 low: -85.326 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 3.127 | |
| CapEx To Revenue | -0.006 | |
| CapEx To Depreciation | -0.539 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 2.5 B | |
| Net Invested Capital | $ 2.5 B | |
| Invested Capital | $ 2.5 B | |
| Net Tangible Assets | $ -566.43 M | |
| Net Working Capital | $ 458.9 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.376 | |
| Current Ratio | 1.557 | |
| Current Ratio QoQ | 2.488 % | |
| Current Ratio YoY | -10.072 % | |
| Current Ratio IPRWA | high: 6.656 OPCH: 1.557 mean: 1.248 median: 0.832 low: 0.014 |
|
| Quick Ratio | 1.052 | |
| Quick Ratio QoQ | 5.5 % | |
| Quick Ratio YoY | -20.538 % | |
| Quick Ratio IPRWA | high: 6.866 OPCH: 1.052 mean: 1.017 median: 0.627 low: 0.013 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 12.742 | |
| Cost Of Debt | 0.848 % | |
| Interest Coverage Ratio | 5.875 | |
| Interest Coverage Ratio QoQ | 1.889 % | |
| Interest Coverage Ratio YoY | -15.562 % | |
| Interest Coverage Ratio IPRWA | high: 30.491 OPCH: 5.875 mean: 1.927 median: 1.798 low: -59.14 |
|
| Operating Cash Flow Ratio | 0.123 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 48.451 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 2.868 % | |
| Revenue Growth | 1.337 % | |
| Revenue Growth QoQ | -78.557 % | |
| Revenue Growth YoY | -68.053 % | |
| Revenue Growth IPRWA | high: 14.194 % mean: 2.906 % median: 2.066 % OPCH: 1.337 % low: -22.095 % |
|
| Earnings Growth | 9.756 % | |
| Earnings Growth QoQ | 290.24 % | |
| Earnings Growth YoY | 192.709 % | |
| Earnings Growth IPRWA | high: 131.373 % OPCH: 9.756 % mean: -6.88 % median: -11.602 % low: -234.091 % |
|
| MARGINS | ||
| Gross Margin | 19.017 % | |
| Gross Margin QoQ | 0.095 % | |
| Gross Margin YoY | -5.299 % | |
| Gross Margin IPRWA | high: 87.689 % mean: 28.202 % median: 27.141 % OPCH: 19.017 % low: -9.25 % |
|
| EBIT Margin | 5.792 % | |
| EBIT Margin QoQ | -1.547 % | |
| EBIT Margin YoY | -13.784 % | |
| EBIT Margin IPRWA | high: 32.526 % OPCH: 5.792 % mean: 5.507 % median: 1.971 % low: -105.324 % |
|
| Return On Sales (ROS) | 5.889 % | |
| Return On Sales QoQ | 0.822 % | |
| Return On Sales YoY | -12.34 % | |
| Return On Sales IPRWA | high: 29.872 % mean: 8.081 % median: 6.252 % OPCH: 5.889 % low: -43.781 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 130.2 M | |
| Free Cash Flow Yield | 2.872 % | |
| Free Cash Flow Yield QoQ | 71.77 % | |
| Free Cash Flow Yield YoY | -1.102 % | |
| Free Cash Flow Yield IPRWA | high: 14.006 % OPCH: 2.872 % mean: 1.516 % median: 1.231 % low: -24.179 % |
|
| Free Cash Growth | 60.322 % | |
| Free Cash Growth QoQ | -110.227 % | |
| Free Cash Growth YoY | -419.012 % | |
| Free Cash Growth IPRWA | high: 558.205 % OPCH: 60.322 % mean: -7.564 % median: -48.314 % low: -423.827 % |
|
| Free Cash To Net Income | 2.514 | |
| Cash Flow Margin | 7.044 % | |
| Cash Flow To Earnings | 1.951 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.51 % | |
| Return On Assets QoQ | 0.0 % | |
| Return On Assets YoY | -5.031 % | |
| Return On Assets IPRWA | high: 7.577 % OPCH: 1.51 % median: 0.39 % mean: 0.309 % low: -22.496 % |
|
| Return On Capital Employed (ROCE) | 3.129 % | |
| Return On Equity (ROE) | 0.038 | |
| Return On Equity QoQ | 2.665 % | |
| Return On Equity YoY | 1.006 % | |
| Return On Equity IPRWA | high: 0.378 OPCH: 0.038 mean: 0.014 median: 0.011 low: -0.391 |
|
| DuPont ROE | 3.812 % | |
| Return On Invested Capital (ROIC) | 2.476 % | |
| Return On Invested Capital QoQ | 0.081 % | |
| Return On Invested Capital YoY | -118.765 % | |
| Return On Invested Capital IPRWA | high: 8.725 % OPCH: 2.476 % median: 0.766 % mean: 0.584 % low: -22.633 % |
|